title: Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.
abstract: The present study characterizes the effects of lysophosphatidic acid (LPA) on blood-brain barrier (BBB) permeability focusing specifically on the time of onset, duration, and magnitude of LPA-induced changes in cerebrovascular permeability in the mouse using both magnetic resonance imaging (MRI) and near infrared fluorescence imaging (NIFR). Furthermore, potential application of LPA for enhanced drug delivery to the brain was also examined by measuring the brain accumulation of radiolabeled methotrexate. Exposure of primary cultured brain microvessel endothelial cells (BMECs) to LPA produced concentration-dependent increases in permeability that were completely abolished by clostridium toxin B. Administration of LPA disrupted BBB integrity and enhanced the permeability of small molecular weight marker gadolinium diethylenetriaminepentaacetate (Gd-DTPA) contrast agent, the large molecular weight permeability marker, IRdye800cwPEG, and the P-glycoprotein efflux transporter probe, Rhodamine 800 (R800). The increase in BBB permeability occurred within 3 minutes after LPA injection and barrier integrity was restored within 20 minutes. A decreased response to LPA on large macromolecule BBB permeability was observed after repeated administration. The administration of LPA also resulted in 20-fold enhancement of radiolabeled methotrexate in the brain. These studies indicate that administration of LPA in combination with therapeutic agents may increase drug delivery to the brain.
authors.affiliation: Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: Ngoc H
authors.initials: NH
authors.lastname: On
authors.forename: Sanjot
authors.initials: S
authors.lastname: Savant
authors.forename: Myron
authors.initials: M
authors.lastname: Toews
authors.forename: Donald W
authors.initials: DW
authors.lastname: Miller
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000378:metabolism; D001921:Brain / Q000098:blood supply* / Q000378:metabolism; D002417:Cattle; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D008246:Lysophospholipids / Q000008:administration & dosage / Q000494:pharmacology*; D008279:Magnetic Resonance Imaging; D051379:Mice; D008807:Mice, Inbred BALB C; D061848:Optical Imaging; D010539:Permeability / Q000187:drug effects*; D012333:RNA, Messenger / Q000235:genetics; D049368:Receptors, Lysophosphatidic Acid / Q000235:genetics / Q000378:metabolism
chemical_list: D008246:Lysophospholipids; D012333:RNA, Messenger; D049368:Receptors, Lysophosphatidic Acid; C032881:lysophosphatidic acid
references.citation: Microcirculation. 2010 Jan;17(1):39-46
references.pmid: 20141599
references.citation: ScientificWorldJournal. 2002 Feb 06;2:324-38
references.pmid: 12806020
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 1:S379-88
references.pmid: 18059321
references.citation: J Biol Chem. 2007 Feb 23;282(8):5814-24
references.pmid: 17172642
references.citation: Biochem J. 1999 Jun 15;340 ( Pt 3):677-86
references.pmid: 10359651
references.citation: J Cell Biochem. 2004 Aug 15;92(6):1086-94
references.pmid: 15258894
references.citation: Am J Physiol. 1995 May;268(5 Pt 2):H2048-55
references.pmid: 7771554
references.citation: Neurosurgery. 1998 May;42(5):1083-99; discussion 1099-100
references.pmid: 9588554
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S225-30
references.pmid: 19066402
references.citation: Am J Physiol. 1998 Jan;274(1):H115-22
references.pmid: 9458859
references.citation: Cell. 1989 Oct 6;59(1):45-54
references.pmid: 2551506
references.citation: Pharm Res. 2011 Oct;28(10):2505-15
references.pmid: 21598079
references.citation: Nat Rev Cancer. 2003 Aug;3(8):582-91
references.pmid: 12894246
references.citation: J Neurooncol. 2013 Jan;111(2):133-43
references.pmid: 23184143
references.citation: Rev Physiol Biochem Pharmacol. 2008;160:25-46
references.pmid: 18481029
references.citation: J Virol. 2006 Dec;80(23):11432-46
references.pmid: 17005646
references.citation: Neurol Res. 2008 May;30(4):366-9
references.pmid: 18544253
references.citation: J Biol Chem. 2009 Sep 4;284(36):24123-32
references.pmid: 19586906
references.citation: J Cell Biol. 1996 Nov;135(4):1071-83
references.pmid: 8922387
references.citation: J Nucl Med. 2007 Sep;48(9):1501-10
references.pmid: 17785729
references.citation: Mol Cell Neurosci. 2003 Dec;24(4):1170-9
references.pmid: 14697676
references.citation: J Hematother Stem Cell Res. 1999 Dec;8(6):627-34
references.pmid: 10645770
references.citation: Bioessays. 2004 Aug;26(8):870-81
references.pmid: 15273989
references.citation: J Neurochem. 1997 Mar;68(3):991-1000
references.pmid: 9048744
references.citation: J Immunol. 2006 Jun 15;176(12):7666-75
references.pmid: 16751414
references.citation: J Neurochem. 1990 Jun;54(6):1882-8
references.pmid: 2338547
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L749-60
references.pmid: 15591411
references.citation: Cell Signal. 2009 Mar;21(3):367-77
references.pmid: 18996473
references.citation: Biochem J. 2009 May 1;419(3):611-8
references.pmid: 19215222
references.citation: Brain Res. 2005 Jun 28;1048(1-2):24-31
references.pmid: 15916752
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Mar;292(3):R1174-83
references.pmid: 17122328
references.citation: J Drug Target. 2010 Apr;18(3):157-67
references.pmid: 20064077
references.citation: Biochem Biophys Res Commun. 2007 Nov 23;363(3):861-6
references.pmid: 17905198
references.citation: Biochem J. 2005 Feb 1;385(Pt 3):677-84
references.pmid: 15369458
references.citation: Clin Pharmacokinet. 2011 May;50(5):281-94
references.pmid: 21366359
references.citation: Cell Tissue Res. 2010 Jul;341(1):23-32
references.pmid: 20495828
references.citation: Acta Physiol (Oxf). 2012 Apr;204(4):469-78
references.pmid: 22260256
references.citation: BMC Neurol. 2009 Jun 12;9 Suppl 1:S3
references.pmid: 19534732
references.citation: Annu Rev Pharmacol Toxicol. 2010;50:157-86
references.pmid: 20055701
references.citation: Brain Res. 2003 Aug 15;981(1-2):30-40
references.pmid: 12885423